ENTRY       D11359                      Drug
NAME        Dasiglucagon (USAN)
FORMULA     C152H222N38O50
EXACT_MASS  3379.5997
MOL_WEIGHT  3381.6137
SEQUENCE    HSQGTFTSDY SKYLDXARAE EFVKWLEST
  TYPE      Peptide
REMARK      ATC code: H04AA02
            Chemical structure group: DG03173
            Product (DG03173): D12314<US>
EFFICACY    Antidiabetic, Antihypoglycemia, Glucagon receptor agonist
  DISEASE   Diabetes mellitus [DS:H00408 H00409]
COMMENT     Glucagon analogue
            Treatment of hypoglycemia in type 1 and type 2 diabetes patients
TARGET      GCGR [HSA:2642] [KO:K04583]
  PATHWAY   hsa04080(2642)  Neuroactive ligand-receptor interaction
            hsa04922(2642)  Glucagon signaling pathway
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
              H04 PANCREATIC HORMONES
               H04A GLYCOGENOLYTIC HORMONES
                H04AA Glycogenolytic hormones
                 H04AA02 Dasiglucagon
                  D11359  Dasiglucagon (USAN)
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Secretin receptor family
               Glucagon
                GCGR
                 D11359  Dasiglucagon (USAN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11359
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11359
DBLINKS     CAS: 1544300-84-6
            PubChem: 384585337
///
